Vertex Pharmaceuticals net common equity issued/repurchased for the twelve months ending March 31, 2025 was $-2.530B, a 269.13% increase year-over-year.
Vertex Pharmaceuticals annual net common equity issued/repurchased for 2024 was $-1.063B, a 262.63% increase from 2023.
Vertex Pharmaceuticals annual net common equity issued/repurchased for 2023 was $-0.293B, a 257.27% decline from 2022.
Vertex Pharmaceuticals annual net common equity issued/repurchased for 2022 was $0.186B, a 114.08% decline from 2021.
Vertex Pharmaceuticals Net Common Equity Issued/Repurchased 2010-2025 | VRTX